JP2022514148A5 - - Google Patents
Info
- Publication number
- JP2022514148A5 JP2022514148A5 JP2021518202A JP2021518202A JP2022514148A5 JP 2022514148 A5 JP2022514148 A5 JP 2022514148A5 JP 2021518202 A JP2021518202 A JP 2021518202A JP 2021518202 A JP2021518202 A JP 2021518202A JP 2022514148 A5 JP2022514148 A5 JP 2022514148A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cdr
- bispecific binding
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862740337P | 2018-10-02 | 2018-10-02 | |
| US62/740,337 | 2018-10-02 | ||
| PCT/JP2019/038750 WO2020071365A1 (en) | 2018-10-02 | 2019-10-01 | Bi-specific binding agents targeting syndecan-1 and fibroblast growth factor receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514148A JP2022514148A (ja) | 2022-02-10 |
| JPWO2020071365A5 JPWO2020071365A5 (https=) | 2022-07-28 |
| JP2022514148A5 true JP2022514148A5 (https=) | 2022-07-28 |
Family
ID=70055592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518202A Withdrawn JP2022514148A (ja) | 2018-10-02 | 2019-10-01 | シンデカン－１および線維芽細胞増殖因子受容体を標的とする二重特異性結合物質 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220249679A1 (https=) |
| EP (1) | EP3861117A4 (https=) |
| JP (1) | JP2022514148A (https=) |
| KR (1) | KR20210070307A (https=) |
| CN (1) | CN113039271A (https=) |
| AR (1) | AR116563A1 (https=) |
| AU (1) | AU2019353367A1 (https=) |
| BR (1) | BR112021005465A2 (https=) |
| CA (1) | CA3107423A1 (https=) |
| IL (1) | IL281929A (https=) |
| MX (1) | MX2021003861A (https=) |
| PH (1) | PH12021500023A1 (https=) |
| SG (1) | SG11202103143UA (https=) |
| TW (1) | TW202028459A (https=) |
| WO (1) | WO2020071365A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4110404A1 (en) * | 2020-02-28 | 2023-01-04 | Genzyme Corporation | Modified binding polypeptides for optimized drug conjugation |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006048877A2 (en) * | 2004-11-04 | 2006-05-11 | Fibron Limited | Treatment of b-cell malignancies with fgfr3 inhibitors |
| ES2526433T3 (es) * | 2007-12-26 | 2015-01-12 | Biotest Ag | Inmunoconjugados dirigidos a CD138 y usos de los mismos |
| WO2012158818A2 (en) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| WO2013082254A1 (en) * | 2011-12-02 | 2013-06-06 | Ibc Pharmaceuticals, Inc. | Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| MX358680B (es) * | 2011-12-08 | 2018-08-31 | Biotest Ag | Usos de inmunoconjugados dirigidos a cd138. |
| CA2861031C (en) * | 2012-02-03 | 2022-10-25 | Carole BOURQUIN | Bispecific antibody molecules with antigen-transfected t-cells and their use in medicine |
| HK1211208A1 (zh) * | 2012-08-22 | 2016-05-20 | Immunogen, Inc. | 細胞毒性苯並二氮呯衍生物 |
| US9803021B2 (en) * | 2012-12-07 | 2017-10-31 | The Regents Of The University Of California | CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| US10323095B2 (en) * | 2014-03-17 | 2019-06-18 | Mitsubishi Tanabe Pharma Corporation | Antibody-fynomer conjugates |
| RU2611685C2 (ru) * | 2015-07-20 | 2017-02-28 | Илья Владимирович Духовлинов | Гуманизированное моноклональное антитело, специфичное к синдекану-1 |
| EP3577133A1 (en) * | 2017-02-06 | 2019-12-11 | Orionis Biosciences NV | Targeted chimeric proteins and uses thereof |
| US10722589B2 (en) * | 2017-04-03 | 2020-07-28 | Covagen Ag | FGFR3 binding molecules |
| CN110691793A (zh) * | 2017-04-26 | 2020-01-14 | 田边三菱制药株式会社 | 黏结蛋白聚糖-1（cd138）结合剂及其用 |
| JP2021165268A (ja) * | 2020-04-07 | 2021-10-14 | 田辺三菱製薬株式会社 | シンデカン−１および線維芽細胞増殖因子受容体を標的とする二重特異性結合物質を含む医薬組成物 |
-
2019
- 2019-10-01 AU AU2019353367A patent/AU2019353367A1/en not_active Abandoned
- 2019-10-01 US US17/282,368 patent/US20220249679A1/en not_active Abandoned
- 2019-10-01 BR BR112021005465-0A patent/BR112021005465A2/pt not_active IP Right Cessation
- 2019-10-01 AR ARP190102778A patent/AR116563A1/es not_active Application Discontinuation
- 2019-10-01 MX MX2021003861A patent/MX2021003861A/es unknown
- 2019-10-01 WO PCT/JP2019/038750 patent/WO2020071365A1/en not_active Ceased
- 2019-10-01 JP JP2021518202A patent/JP2022514148A/ja not_active Withdrawn
- 2019-10-01 KR KR1020217011453A patent/KR20210070307A/ko not_active Withdrawn
- 2019-10-01 SG SG11202103143UA patent/SG11202103143UA/en unknown
- 2019-10-01 PH PH1/2021/500023A patent/PH12021500023A1/en unknown
- 2019-10-01 CA CA3107423A patent/CA3107423A1/en active Pending
- 2019-10-01 CN CN201980064967.7A patent/CN113039271A/zh active Pending
- 2019-10-01 EP EP19869146.1A patent/EP3861117A4/en not_active Withdrawn
- 2019-10-01 TW TW108135510A patent/TW202028459A/zh unknown
-
2021
- 2021-03-31 IL IL281929A patent/IL281929A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6908722B2 (ja) | 抗ｐｄ−１抗体及びその使用 | |
| RU2743590C2 (ru) | Молекулы со специфичностью в отношении cd79 и cd22 | |
| JP7161400B2 (ja) | Ｃｄ２２に結合する抗体分子 | |
| EP2545076B1 (en) | Biological products: humanised agonistic anti-pd-1 antibodies | |
| JP2024125370A (ja) | クローディン１８．２結合部分およびその利用 | |
| CN102421802B (zh) | 人源化的axl抗体 | |
| AU2018295119B2 (en) | Multi-specific antibodies and methods of making and using thereof | |
| JP6998857B2 (ja) | Ｃｄ７９に結合する抗体分子 | |
| JP2024056687A5 (https=) | ||
| JP2021501162A5 (https=) | ||
| JP2020504723A5 (https=) | ||
| JP2011046732A5 (https=) | ||
| JP2016503067A5 (https=) | ||
| JP2018093875A5 (https=) | ||
| WO2019196309A1 (zh) | 抗pd-l1抗体及其用途 | |
| JP2021520195A5 (https=) | ||
| JP2021519319A5 (https=) | ||
| KR102567489B1 (ko) | 세포 연계 결합 분자 | |
| CN113574069A (zh) | 抗pd-l1抗体及其用途 | |
| JP2022514148A5 (https=) | ||
| CN114829398B (zh) | 对人il-13具有结合特异性的抗体 | |
| CN114573703A (zh) | 一种t细胞衔接器治疗剂的开发和应用 | |
| IL319999A (en) | Bispecific antibodies against CD3 and CD20 - for the treatment of Richter syndrome | |
| JPWO2021068841A5 (https=) | ||
| JPWO2020071365A5 (https=) |